Terns Pharmaceuticals, Inc.

NASDAQ:TERN

7.06 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q12019 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 91.49665.09979.92637.89380.919184.354143.23562.97716.80643.87947.69964.75167.58998.82974.85413.756-19.6512.327
Short Term Investments 133.801175.555183.514228.707204.684113.172139.879124.309123.004107.389118.283112.445117.49596.7520039.37.323
Cash and Short Term Investments 225.297240.654263.44266.6285.603297.526283.114187.286139.81151.268165.982177.196185.084195.58174.85413.75619.6519.65
Net Receivables 0000000000000012.718000
Inventory 000000000000002.966000
Other Current Assets 4.9415.2413.9923.8552.7122.1382.0713.2512.7912.8430.9481.5981.7882.4610.3310.63200.461
Total Current Assets 230.238245.895267.432270.455288.315297.526285.185190.537142.601154.111166.93178.794186.872198.04290.86915.42119.6522.224
Non-Current Assets:
Property, Plant & Equipment, Net 0.5870.8161.0291.1971.3461.5841.8042.0022.1952.4861.0460.9270.9591.0251.1751.23400.961
Goodwill 000000000000000000
Intangible Assets 000000000000000000
Goodwill and Intangible Assets 000000000000000000
Long Term Investments 000000000000000000
Tax Assets 000000000000000000
Other Non-Current Assets 0.0550.0550.0560.0350.0362.1750.0370.0470.0640.0720.0940.1690.1760.1740.2460.758-19.650.719
Total Non-Current Assets 0.6420.8711.0851.2321.3823.7591.8412.0492.2592.5581.141.0961.1351.1991.4211.992-19.651.68
Total Assets 230.88246.766268.517271.687289.697301.285287.026192.586144.86156.669168.07179.89188.007199.24192.2917.413023.904
Liabilities & Equity:
Current Liabilities:
Account Payables 1.8731.7012.5153.3255.5372.691.6452.0940.9731.6782.1261.5821.6884.250.9350.46101.636
Short Term Debt 0.2490.4270.6030.7070.6530.6560.6610.6650.5860.58404.3923.1633.20812.8819.33700
Tax Payables 1.2441.2181.20601.0861.1071.0710.7090.7490.7880.7870.6650.6640.6540.657000
Deferred Revenue 1.2441.21807.6631.0860000000.8360.8360.8360.8367.6700
Other Current Liabilities 7.5895.4828.8260.3926.9628.7636.1624.7224.4853.9034.6940.0830.1310.0838.170.55503.314
Total Current Liabilities 10.9558.82811.94412.08714.23812.1098.4687.4816.0446.1656.826.8935.8188.37722.82128.02304.95
Non-Current Liabilities:
Long Term Debt 0000.0630.2230.3860.5440.7020.851100000000
Deferred Revenue Non-Current 000000000000000000
Deferred Tax Liabilities Non-Current 00000000000.78700000.35400.345
Other Non-Current Liabilities 1.2441.2181.2061.1121.0861.1071.0710.7090.7490.7880.160.8410.8570.8620.87713.884014.402
Total Non-Current Liabilities 1.2441.2181.2061.1751.3091.4931.6151.4111.61.7880.9470.8410.8570.8620.87714.238014.747
Total Liabilities 12.19910.04613.1513.26215.54713.60210.0838.8927.6447.9537.7677.7346.6759.23923.69842.261019.697
Equity:
Preferred Stock 00000000000179.89188.007199.241186.03394.96794.96794.967
Common Stock 0.0070.0060.0060.0060.0060.0050.0050.0040.0030.0030.0030.0030.0030.0030000
Retained Earnings -377.737-355.001-332.628-311.609-281.842-263.946-242.418-226.596-209.776-195.846-182.073-167.825-155.99-145.252-131.915-121.9860-91.862
Accumulated Other Comprehensive Income/Loss -0.443-0.321-0.019-0.836-0.775-0.416-0.822-1.348-1.241-0.896-0.338-0.167-0.174-0.232-0.1240.09-90.76-0.106
Other Total Stockholders Equity 596.854592.036588.008570.864556.761552.04520.178411.634348.23345.455342.711160.255149.486136.24214.5982.08114.1171.208
Total Shareholders Equity 218.681236.72255.367258.425274.15287.683276.943183.694137.216148.716160.303172.156181.332190.00268.592-24.84818.3244.207
Total Equity 218.681236.72255.367258.425274.15287.683276.943183.694137.216148.716160.303172.156181.332190.00268.592-11.24918.32418.324
Total Liabilities & Shareholders Equity 230.88246.766268.517271.687289.697301.285287.026192.586144.86156.669168.07179.89188.007199.24192.2917.41318.32423.904